International Study of Pulmonary Segmentectomy Surgery Outcomes in Stage I Lung Cancer Patients

What this Trial Is About

Researchers are studying patients with Stage I lung cancer who are undergoing planned pulmonary segmentectomy surgery. The study aims to understand the disease-free survival rates at 3 and 5 years after this surgery in people suitable for this procedure based on clinical staging. Patients with suspected non-small cell lung cancer are included, even if tissue diagnosis is not confirmed before surgery. Participants in this observational study complete questionnaires using the Patient-Reported Outcomes Measurement Information System PROMIS, which evaluates physical function, pain interference, and breathing difficulty. These questionnaires are completed before surgery, between 2 to 4 weeks after surgery, and again 6 months after surgery. The study collects data through this web-based platform developed by the National Institutes of Health. During the study, participants are asked to fill out surveys at specified times to assess their health and symptoms. Researchers will track disease-free survival over 3 and 5 years after surgery to evaluate outcomes. Participation involves completing questionnaires and follow-up over several years, with no investigational treatment being administered. The total study completion is expected by May 2029.

A Registry for People With Lung Cancer